ArticleBlood advances2022

Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment.

Raphael Teipel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.